How to prevent the recurrence of interstitial pneumonia in winter and how to treat patients with int

Interstitial pneumonia requires moderate exercise, which is conducive to strengthening the body's immune function and can prevent the onset of pneumonia. Most of the disease is caused by working in toxic environments for long periods of time, and the abuse of interferon at home can also increase the risk of developing the disease. Most people will have difficulty breathing and dry cough, but if the disease is severe, it can also cause chest pain, and most people will also have skeletal muscle pain and weight loss.

It is necessary to use anti-inflammatory drugs under the doctor's advice to keep the condition under control.

There are more and more patients with interstitial pneumonia, interstitial pneumonia is a disease that is easy to suffer, the disease has brought great pain to the patient's body, and has brought great harm to the patient's family, so how to prevent interstitial pneumonia?

1. Keep warm in winter.

Patients with interstitial pneumonia generally have worse disease in winter, so patients with interstitial pneumonia must wear thick clothes to keep warm in winter. In order to avoid the aggravation of interstitial pneumonia due to colds.

2. Pay attention to weather changes in summer.

Patients with interstitial pneumonia should pay attention to the change of weather in the summer, and the weather will become cooler when it rains, so they must remember to increase clothing.

3. Improve immunity.

Patients with interstitial pneumonia must improve their immunity to avoid aggravation of the disease or **, improving immunity can allow patients to better fight the disease. Patients can do a moderate amount of exercise, and consistent exercise can strengthen the patient's resistance. Pay attention to the changes in the weather when exercising, and pay attention to protective measures when the weather is bad or you can do indoor sports.

Patients with interstitial pneumonia can also ensure nutrition in their diet to improve their resistance, eat some protein-rich foods, eat more vegetables and fruits, and supplement vitamins in time. Reasonable eating habits have certain benefits for the disease.

In general, pneumonia refers to infectious inflammation of the alveoli, distal airways, and lung interstitium, which can be caused by bacterial, viral, and other pathogens, with bacterial and viral pneumonia being the most common. Broadly speaking, pneumonia can be caused by pathogenic microorganisms, physicochemical factors, immune damage, allergies, and drugs.

Patients often have typical symptoms such as fever, cough, and difficulty breathing. Viral pneumonia can be spread through the air.

1. The conventional starting dose of corticosteroids for chronic type is prednisone 30 40mg daily, divided into 3 4 times. When the condition is stable, the X-ray shadow is no longer absorbed, the dose can be gradually reduced, about 4 to 6 weeks after 5 mg each time, to be reduced to 20 mg a day, each time to reduce, if the patient feels unstable, the dose should be reduced more slowly, or even only 1 mg each time. The maintenance dose should not be less than 10mg per day, and the course of treatment should not be less than 1 year.

If the disease recurs during the dose reduction, the dose should be increased again to control the disease, which is still effective. If the condition requires, it can be taken for life. **After the initiation, the vast majority of patients have improved or significantly improved their clinical symptoms in a short period of time, while the X-ray shadow of the lungs has not changed significantly.

If the disease is acute or has progressed to a severe hypoxic stage, corticosteroids should be started in high doses to allow for rapid reversal. Prednisone 60 80 mg daily, applied in 3 divided doses of 4 times. If the disease is dangerous, use the shock**, intravenous methylprednisolone 500 1000mg daily for 3 5 days, and then change to oral administration when the condition is stable, and finally find the optimal maintenance amount according to individual differences to avoid**.

2. Immunosuppressant corticosteroid efficacy is not ideal, immunosuppressant or combination drug can be used, but the effect is to be determined.

Azathioprine: is the drug of choice, the dose is 100 mg daily, orally once a day, *** small.

cyclophosphamide: dose 100 mg daily orally. Not as effective as azathioprine. Its *** force bone marrow suppression, etc., so it should be closely observed.

Tripterygium wilfordii polyglycosides: have definite anti-inflammatory, immunosuppressive effects, combined with hormones or immunosuppressants can reduce the dose of the above two drugs and increase the efficacy, the dose is 10 20 mg, 3 times a day, oral.

3. Symptomatic** In case of secondary infection, antibiotics should be selected according to the type of bacteria; Hypoxemia may be given with low-flow oxygen inhalation.

1.Factors: such as avoiding contact with the environment and other factors.

2.Some types of interstitial pneumonia require glucocorticoids plus immunosuppressants**. 3.

Antifibrotic drugs may be used for idiopathic pulmonary fibrosis (IPF) and some types of secondary interstitial pneumonia**. 4.Lung transplantation in patients with advanced disease is the only effective measure.

5.Can be combined with traditional Chinese medicine**. 6.

Oxygen is given, and mechanical ventilation corrects hypoxia if necessary. 7.Be aware of comorbidities and complications**.

8.and functional exercises.

Drugs**. Sugar, immunosuppressants, anti-fibrotic drugs and traditional Chinese medicine, etc. Commonly used drugs: prednisone acetate tablets, cyclophosphamide, azathioprine, pirfenidone, nintedanib, etc.

Surgery**. Lung transplant.

Prognosis. The prognosis varies greatly depending on **. The average survival time for idiopathic pulmonary fibrosis is 3 to 5 years; Nonspecific interstitial pneumonia can be cured after positive**; The prognosis of cryptogenic organizing pneumonia is good; Lymphocytic interstitial pneumonia has a mortality rate of 33% to 50% within 5 years.

Prognosis. The prognosis varies greatly depending on **. The average survival time for idiopathic pulmonary fibrosis is 3 to 5 years; Nonspecific interstitial pneumonia can be cured after positive**; The prognosis of cryptogenic organizing pneumonia is good; Lymphocytic interstitial pneumonia has a mortality rate of 33% to 50% within 5 years.

Interstitial pneumonia is a relatively common chronic disease, and it is a type of respiratory disease. Many people do not pay much attention to this disease, interstitial pneumonia will have a great impact on the patient's body, and in severe cases, it can even cause suffocation, so enough attention should be paid to it. Patients with interstitial pneumonia often have difficulty breathing, which can be managed by diet, medication, and daily life.

Interstitial pneumonia is a disease in which the interstitium of the lungs is the main site of lesions, and a variety of causes can cause interstitial pneumonia. It is characterized by frequent dry cough, chest tightness, and dyspnea after exertion. Patients with interstitial pneumonia may also experience loss of appetite and physical emaciation.

If the patient finds that he has dyspnea, fatigue, general weakness, etc., he should go to the hospital for examination in time, clarify ** as soon as possible, and make corresponding **. For patients with interstitial pneumonia, it is necessary to carry out timely conditioning and **, so what are the conditioning methods for qualitative pneumonia?

1. Patients with interstitial pneumonia can be dieted, usually eat some fresh vegetables and fruits, and supplement more nutrients they need, which will help improve their immunity and speed up the recovery of the disease. Eat more foods that are high in protein, such as lean meat, shrimp, fish, etc. Drink more warm water, patients with severe interstitial pneumonia will sweat a lot and eat less, they are easily dehydrated, so they need to replenish their own water in time, and can also dilute the sputum, which is conducive to the recovery of the patient's condition.

2. Patients with interstitial pneumonia can also choose some drugs to regulate under the guidance and advice of doctors**, and glucocorticoids can be used for anti-inflammatory**, which can effectively alleviate the inflammatory symptoms of the patient's lungs. Some antibiotics and antifungal drugs may also be used, depending on the patient's specific condition.

The fibrotic changes in the lungs of patients with interstitial pneumonia cannot be reversed, and the best clinical approach is to reduce the inflammatory response and prevent or alleviate pulmonary fibrosis.

thereby improving the patient's quality of life and prolonging survival. Known causative or predisposing factors should be avoided first, and for interstitial pneumonia secondary to connective tissue disease, the primary disease needs to be avoided.

In an acute exacerbation of idiopathic pulmonary fibrosis, the disease progresses rapidly, and the patient quickly develops respiratory failure, with short survival and high mortality.

The main clinical strategy is symptomatic support. Acute respiratory failure.

patients with high-flow oxygen to improve hypoxia, and mechanical ventilation in patients with acute respiratory deterioration should be weighed. Medications** High-dose corticosteroids are often used, and antibiotics are used to control infection. The role of antifibrotic drugs in the acute exacerbation of idiopathic pulmonary fibrosis is uncertain.

Once the patient is stable, a lung transplant may be considered.

Interstitial pneumonia can be removed**, medications**, symptomatic**, lung transplantation**.

Interstitial pneumonia should be active, relatively complex, and the specific methods are as follows.

1. Removal, for known amalgamation, try to remove it, mainly to get rid of the relevant dust occupational environment, stop drugs that can cause pulmonary fibrosis such as amiodarone, bleomycin, etc., to avoid radiation damage, connective tissue diseases, etc.

2. Drugs**, will have an effect on interstitial pneumonia with alveolitis-based lesions, can improve symptoms and improve lung function, and has basically no effect on cases of extensive interstitial fibrosis, and can use large doses of hormone shock in the acute stage**, all of which are methylprednisolone, and gradually changed to oral after intravenous application, with a total course of not less than one year, and immunosuppressants, such as azathioprine, cyclophosphamide, etc., The antifibrotic drug than fenidone can slow the deterioration of lung function or reduce the frequency of exacerbations to some extent.

3. For symptomatic **, it is recommended to use antibiotics for secondary infection**, expectorant for those with more phlegm**, oxygen inhalation, assisted ventilation, and ventilator for respiratory failure**, the effect is not necessarily ideal.

4. Lung transplantation**, diffuse lesions of both lungs, drugs**, its**ineffective, consider lung transplantation**.

Interstitial pneumonia is a general term for a large group of diseases, and it is necessary to clarify the ** of interstitial pneumonia and carry out ** for the type of pneumonia, as follows:

1. For idiopathic pulmonary fibrosis, pirfenidone and nintedanib are recommended clinically, and only pirfenidone is marketed in China, which is mainly a drug to control disease progression;

2. For non-specific interstitial pneumonia, clinical use of hormones**;

3. Use hormones to control symptoms of secondary pneumonia;

4. For desquamative interstitial pneumonia and respiratory bronchiolitis, the main thing is to quit smoking, with hormones**;

5. Acute attacks of interstitial pneumonia require the use of hormones.

At present, there is no specific drug for interstitial pneumonia, and only drugs can be used to control the condition.

The first step in clinical practice is to determine whether it is primary, that is, idiopathic pulmonary interstitial pneumonia or secondary pulmonary interstitial pneumonia. Most idiopathic interstitial pneumonitis is an autoimmune disease that generally requires glucocorticoids plus immunosuppressants**.

What are the dietary principles for patients with interstitial pneumonia? It is necessary to understand the general condition of the patient, including age, gender, occupation, etc., as well as past medical history, current medical history, nutritional history, and whether there is a history of gluttony and food allergies. Combined with interstitial pneumonia symptoms and**.

Interstitial pneumonia is a disease that predisposes to **, and there are many types of specific interstitial pneumonia.

How to prevent interstitial pneumonia, first of all, we must clarify its pathological type. For example, some idiopathic interstitial pneumonia, this ** effect is not very good, so it may have a worsening of the condition, or even some sudden death, so this disease should be early**; For example, some antioxidants are used, some reducing drugs are used, such as acetylcysteine effervescent tablets or some pirfenidone can be used for patients with an economic basis.

If it is some secondary, pulmonary interstitial fibrosis or interstitial pneumonia, some hormones or some immunosuppressants can be used to cure the original disease at the source, and its lung condition may be slowly relieved.

Therefore, it must be the primary disease, which can be said to prevent it fundamentally.

To prevent the recurrence of pneumonia is to actively control the infection when suffering from pneumonia, carry out a sufficient amount and a full course of treatment**, do not stop the drug without authorization, if the symptoms improve, the imaging lesions are better absorbed, and let the specialist judge whether to stop the drug to prevent the recurrence of pneumonia. After recovering from the disease, it is necessary to improve one's physical fitness, participate in more sports, and eat more high-quality foods with high protein content, which can effectively improve the body's disease resistance and immunity, and reduce the reinfection of pneumonia. Susceptible and high-risk groups can be vaccinated against pneumonia and influenza in advance, and preventing the occurrence of respiratory tract infection can also reduce the recurrence of pneumonia in a large sense.

Intermittent pneumonia refers to the intermittent occurrence of symptoms of pneumonia, which is mainly manifested as fever, cough and sputum production. Symptoms may be relieved or disappear after a period of time, and the above symptoms may recur after a period of time. The causes of intermittent pneumonia mainly include environmental factors and the patient's own factors, also known as host factors, if the work, living environment, and hygiene are poor, it is easy to breed various pathogenic microorganisms.